Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant 2021-09-06 13:44
GeneQuantum and BrighGene sign agreement for development of antibody immune agonist conjugates 2021-09-06 09:00
AffaMed Therapeutics Enters into Strategic Partnership Agreement with Beijing Tiantan Hospital and Infinite Brain Technologies to Promote Digital Therapy in Neurological Diseases 2021-09-06 08:00
WuXi AppTec Receives AA ESG Rating from MSCI 2021-09-06 08:00
PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC 2021-09-03 20:00
I-Mab Added to FTSE Russell Global Equity Index Series 2021-09-02 20:00
Senhwa's Silmitasertib, COVID-19 Drug Candidate, Receives Positive Interim Review from Data Monitoring Committee to Proceed 2021-08-31 19:00
Pharmaxis Treatment to Prevent Wound and Burns Scars Clears Phase 1 Trial 2021-08-31 18:00
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2021 2021-08-31 18:00
Harbour BioMed Reports 2021 Interim Results 2021-08-31 13:47
InnoCare Announces Clearance by U.S. FDA of Clinical Trial of pan-TRK Inhibitor ICP-723 2021-08-31 08:30
Through CEO of Hanmi Science, CancerRop Issues KRW 20 Billion New Shares for Cooperation with Oxford Vacmedix 2021-08-30 23:00
I-Mab Announces Upcoming Participation at September Conferences 2021-08-30 20:00
GeneQuantum announces Dr. Yi Xia as Senior Vice President of Statistics and Data Science 2021-08-30 10:00
InnoCare Releases 2021 Half Year Results and Business Highlights 2021-08-29 19:49
IONOVA Life Science Announces New Financing Round of USD $100 Million 2021-08-27 22:00
Laekna Therapeutics Receives IND Approvals in China and US for Phase Ib/III Global Multi-center Clinical Study of Afuresertib in combination with fulvestrant for patients with HR+/HER2- breast cancer 2021-08-27 11:20
PharmaBlock Announces the Appointment of Dr. Xudong Wei as Senior Vice President to Lead and Enhance Small Molecule CDMO Services 2021-08-26 23:00
3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development 2021-08-26 22:09
First patient treated in Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial 2021-08-25 21:18
1 98 99 100 101 102 165